1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Overt Hepatic Encephalopathy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029 1.2.2 Type A (Acute Liver Failure) 1.2.3 Type B (Portal Systemic Bypass Without Liver Disease) 1.2.4 Type C (Liver Cirrhosis) 1.3 Market by Application 1.3.1 Global Overt Hepatic Encephalopathy Market Growth by Application: 2018 VS 2022 VS 2029 1.3.2 Hospitals 1.3.3 Research Institutes 1.3.4 Clinics 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 1.6 Years Considered 2 Global Growth Trends 2.1 Global Overt Hepatic Encephalopathy Market Perspective (2018-2029) 2.2 Overt Hepatic Encephalopathy Growth Trends by Region 2.2.1 Global Overt Hepatic Encephalopathy Market Size by Region: 2018 VS 2022 VS 2029 2.2.2 Overt Hepatic Encephalopathy Historic Market Size by Region (2018-2023) 2.2.3 Overt Hepatic Encephalopathy Forecasted Market Size by Region (2024-2029) 2.3 Overt Hepatic Encephalopathy Market Dynamics 2.3.1 Overt Hepatic Encephalopathy Industry Trends 2.3.2 Overt Hepatic Encephalopathy Market Drivers 2.3.3 Overt Hepatic Encephalopathy Market Challenges 2.3.4 Overt Hepatic Encephalopathy Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Overt Hepatic Encephalopathy Players by Revenue 3.1.1 Global Top Overt Hepatic Encephalopathy Players by Revenue (2018-2023) 3.1.2 Global Overt Hepatic Encephalopathy Revenue Market Share by Players (2018-2023) 3.2 Global Overt Hepatic Encephalopathy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Overt Hepatic Encephalopathy Revenue 3.4 Global Overt Hepatic Encephalopathy Market Concentration Ratio 3.4.1 Global Overt Hepatic Encephalopathy Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Overt Hepatic Encephalopathy Revenue in 2022 3.5 Overt Hepatic Encephalopathy Key Players Head office and Area Served 3.6 Key Players Overt Hepatic Encephalopathy Product Solution and Service 3.7 Date of Enter into Overt Hepatic Encephalopathy Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Overt Hepatic Encephalopathy Breakdown Data by Type 4.1 Global Overt Hepatic Encephalopathy Historic Market Size by Type (2018-2023) 4.2 Global Overt Hepatic Encephalopathy Forecasted Market Size by Type (2024-2029) 5 Overt Hepatic Encephalopathy Breakdown Data by Application 5.1 Global Overt Hepatic Encephalopathy Historic Market Size by Application (2018-2023) 5.2 Global Overt Hepatic Encephalopathy Forecasted Market Size by Application (2024-2029) 6 North America 6.1 North America Overt Hepatic Encephalopathy Market Size (2018-2029) 6.2 North America Overt Hepatic Encephalopathy Market Growth Rate by Country: 2018 VS 2022 VS 2029 6.3 North America Overt Hepatic Encephalopathy Market Size by Country (2018-2023) 6.4 North America Overt Hepatic Encephalopathy Market Size by Country (2024-2029) 6.5 United States 6.6 Canada 7 Europe 7.1 Europe Overt Hepatic Encephalopathy Market Size (2018-2029) 7.2 Europe Overt Hepatic Encephalopathy Market Growth Rate by Country: 2018 VS 2022 VS 2029 7.3 Europe Overt Hepatic Encephalopathy Market Size by Country (2018-2023) 7.4 Europe Overt Hepatic Encephalopathy Market Size by Country (2024-2029) 7.5 Germany 7.6 France 7.7 U.K. 7.8 Italy 7.9 Russia 7.10 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Overt Hepatic Encephalopathy Market Size (2018-2029) 8.2 Asia-Pacific Overt Hepatic Encephalopathy Market Growth Rate by Region: 2018 VS 2022 VS 2029 8.3 Asia-Pacific Overt Hepatic Encephalopathy Market Size by Region (2018-2023) 8.4 Asia-Pacific Overt Hepatic Encephalopathy Market Size by Region (2024-2029) 8.5 China 8.6 Japan 8.7 South Korea 8.8 Southeast Asia 8.9 India 8.10 Australia 9 Latin America 9.1 Latin America Overt Hepatic Encephalopathy Market Size (2018-2029) 9.2 Latin America Overt Hepatic Encephalopathy Market Growth Rate by Country: 2018 VS 2022 VS 2029 9.3 Latin America Overt Hepatic Encephalopathy Market Size by Country (2018-2023) 9.4 Latin America Overt Hepatic Encephalopathy Market Size by Country (2024-2029) 9.5 Mexico 9.6 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Overt Hepatic Encephalopathy Market Size (2018-2029) 10.2 Middle East & Africa Overt Hepatic Encephalopathy Market Growth Rate by Country: 2018 VS 2022 VS 2029 10.3 Middle East & Africa Overt Hepatic Encephalopathy Market Size by Country (2018-2023) 10.4 Middle East & Africa Overt Hepatic Encephalopathy Market Size by Country (2024-2029) 10.5 Turkey 10.6 Saudi Arabia 10.7 UAE 11 Key Players Profiles 11.1 Alfa Wassermann 11.1.1 Alfa Wassermann Company Detail 11.1.2 Alfa Wassermann Business Overview 11.1.3 Alfa Wassermann Overt Hepatic Encephalopathy Introduction 11.1.4 Alfa Wassermann Revenue in Overt Hepatic Encephalopathy Business (2018-2023) 11.1.5 Alfa Wassermann Recent Development 11.2 Cosmo Pharmaceuticals 11.2.1 Cosmo Pharmaceuticals Company Detail 11.2.2 Cosmo Pharmaceuticals Business Overview 11.2.3 Cosmo Pharmaceuticals Overt Hepatic Encephalopathy Introduction 11.2.4 Cosmo Pharmaceuticals Revenue in Overt Hepatic Encephalopathy Business (2018-2023) 11.2.5 Cosmo Pharmaceuticals Recent Development 11.3 Horizon Pharma 11.3.1 Horizon Pharma Company Detail 11.3.2 Horizon Pharma Business Overview 11.3.3 Horizon Pharma Overt Hepatic Encephalopathy Introduction 11.3.4 Horizon Pharma Revenue in Overt Hepatic Encephalopathy Business (2018-2023) 11.3.5 Horizon Pharma Recent Development 11.4 KannaLife Sciences 11.4.1 KannaLife Sciences Company Detail 11.4.2 KannaLife Sciences Business Overview 11.4.3 KannaLife Sciences Overt Hepatic Encephalopathy Introduction 11.4.4 KannaLife Sciences Revenue in Overt Hepatic Encephalopathy Business (2018-2023) 11.4.5 KannaLife Sciences Recent Development 11.5 Ocer Therapeutics 11.5.1 Ocer Therapeutics Company Detail 11.5.2 Ocer Therapeutics Business Overview 11.5.3 Ocer Therapeutics Overt Hepatic Encephalopathy Introduction 11.5.4 Ocer Therapeutics Revenue in Overt Hepatic Encephalopathy Business (2018-2023) 11.5.5 Ocer Therapeutics Recent Development 11.6 Rebiotix 11.6.1 Rebiotix Company Detail 11.6.2 Rebiotix Business Overview 11.6.3 Rebiotix Overt Hepatic Encephalopathy Introduction 11.6.4 Rebiotix Revenue in Overt Hepatic Encephalopathy Business (2018-2023) 11.6.5 Rebiotix Recent Development 11.7 Spherium Biomed 11.7.1 Spherium Biomed Company Detail 11.7.2 Spherium Biomed Business Overview 11.7.3 Spherium Biomed Overt Hepatic Encephalopathy Introduction 11.7.4 Spherium Biomed Revenue in Overt Hepatic Encephalopathy Business (2018-2023) 11.7.5 Spherium Biomed Recent Development 11.8 Umecrine Cognition 11.8.1 Umecrine Cognition Company Detail 11.8.2 Umecrine Cognition Business Overview 11.8.3 Umecrine Cognition Overt Hepatic Encephalopathy Introduction 11.8.4 Umecrine Cognition Revenue in Overt Hepatic Encephalopathy Business (2018-2023) 11.8.5 Umecrine Cognition Recent Development 11.9 ASKA Pharmaceutical 11.9.1 ASKA Pharmaceutical Company Detail 11.9.2 ASKA Pharmaceutical Business Overview 11.9.3 ASKA Pharmaceutical Overt Hepatic Encephalopathy Introduction 11.9.4 ASKA Pharmaceutical Revenue in Overt Hepatic Encephalopathy Business (2018-2023) 11.9.5 ASKA Pharmaceutical Recent Development 11.10 Mallinckrodt 11.10.1 Mallinckrodt Company Detail 11.10.2 Mallinckrodt Business Overview 11.10.3 Mallinckrodt Overt Hepatic Encephalopathy Introduction 11.10.4 Mallinckrodt Revenue in Overt Hepatic Encephalopathy Business (2018-2023) 11.10.5 Mallinckrodt Recent Development 11.11 Valeant 11.11.1 Valeant Company Detail 11.11.2 Valeant Business Overview 11.11.3 Valeant Overt Hepatic Encephalopathy Introduction 11.11.4 Valeant Revenue in Overt Hepatic Encephalopathy Business (2018-2023) 11.11.5 Valeant Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Overt Hepatic Encephalopathy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029 Table 2. Key Players of Type A (Acute Liver Failure) Table 3. Key Players of Type B (Portal Systemic Bypass Without Liver Disease) Table 4. Key Players of Type C (Liver Cirrhosis) Table 5. Global Overt Hepatic Encephalopathy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029 Table 6. Global Overt Hepatic Encephalopathy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Table 7. Global Overt Hepatic Encephalopathy Market Size by Region (2018-2023) & (US$ Million) Table 8. Global Overt Hepatic Encephalopathy Market Share by Region (2018-2023) Table 9. Global Overt Hepatic Encephalopathy Forecasted Market Size by Region (2024-2029) & (US$ Million) Table 10. Global Overt Hepatic Encephalopathy Market Share by Region (2024-2029) Table 11. Overt Hepatic Encephalopathy Market Trends Table 12. Overt Hepatic Encephalopathy Market Drivers Table 13. Overt Hepatic Encephalopathy Market Challenges Table 14. Overt Hepatic Encephalopathy Market Restraints Table 15. Global Overt Hepatic Encephalopathy Revenue by Players (2018-2023) & (US$ Million) Table 16. Global Overt Hepatic Encephalopathy Market Share by Players (2018-2023) Table 17. Global Top Overt Hepatic Encephalopathy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Overt Hepatic Encephalopathy as of 2022) Table 18. Ranking of Global Top Overt Hepatic Encephalopathy Companies by Revenue (US$ Million) in 2022 Table 19. Global 5 Largest Players Market Share by Overt Hepatic Encephalopathy Revenue (CR5 and HHI) & (2018-2023) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Overt Hepatic Encephalopathy Product Solution and Service Table 22. Date of Enter into Overt Hepatic Encephalopathy Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Overt Hepatic Encephalopathy Market Size by Type (2018-2023) & (US$ Million) Table 25. Global Overt Hepatic Encephalopathy Revenue Market Share by Type (2018-2023) Table 26. Global Overt Hepatic Encephalopathy Forecasted Market Size by Type (2024-2029) & (US$ Million) Table 27. Global Overt Hepatic Encephalopathy Revenue Market Share by Type (2024-2029) Table 28. Global Overt Hepatic Encephalopathy Market Size by Application (2018-2023) & (US$ Million) Table 29. Global Overt Hepatic Encephalopathy Revenue Market Share by Application (2018-2023) Table 30. Global Overt Hepatic Encephalopathy Forecasted Market Size by Application (2024-2029) & (US$ Million) Table 31. Global Overt Hepatic Encephalopathy Revenue Market Share by Application (2024-2029) Table 32. North America Overt Hepatic Encephalopathy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 33. North America Overt Hepatic Encephalopathy Market Size by Country (2018-2023) & (US$ Million) Table 34. North America Overt Hepatic Encephalopathy Market Size by Country (2024-2029) & (US$ Million) Table 35. Europe Overt Hepatic Encephalopathy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 36. Europe Overt Hepatic Encephalopathy Market Size by Country (2018-2023) & (US$ Million) Table 37. Europe Overt Hepatic Encephalopathy Market Size by Country (2024-2029) & (US$ Million) Table 38. Asia-Pacific Overt Hepatic Encephalopathy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029 Table 39. Asia-Pacific Overt Hepatic Encephalopathy Market Size by Region (2018-2023) & (US$ Million) Table 40. Asia-Pacific Overt Hepatic Encephalopathy Market Size by Region (2024-2029) & (US$ Million) Table 41. Latin America Overt Hepatic Encephalopathy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 42. Latin America Overt Hepatic Encephalopathy Market Size by Country (2018-2023) & (US$ Million) Table 43. Latin America Overt Hepatic Encephalopathy Market Size by Country (2024-2029) & (US$ Million) Table 44. Middle East & Africa Overt Hepatic Encephalopathy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 45. Middle East & Africa Overt Hepatic Encephalopathy Market Size by Country (2018-2023) & (US$ Million) Table 46. Middle East & Africa Overt Hepatic Encephalopathy Market Size by Country (2024-2029) & (US$ Million) Table 47. Alfa Wassermann Company Detail Table 48. Alfa Wassermann Business Overview Table 49. Alfa Wassermann Overt Hepatic Encephalopathy Product Table 50. Alfa Wassermann Revenue in Overt Hepatic Encephalopathy Business (2018-2023) & (US$ Million) Table 51. Alfa Wassermann Recent Development Table 52. Cosmo Pharmaceuticals Company Detail Table 53. Cosmo Pharmaceuticals Business Overview Table 54. Cosmo Pharmaceuticals Overt Hepatic Encephalopathy Product Table 55. Cosmo Pharmaceuticals Revenue in Overt Hepatic Encephalopathy Business (2018-2023) & (US$ Million) Table 56. Cosmo Pharmaceuticals Recent Development Table 57. Horizon Pharma Company Detail Table 58. Horizon Pharma Business Overview Table 59. Horizon Pharma Overt Hepatic Encephalopathy Product Table 60. Horizon Pharma Revenue in Overt Hepatic Encephalopathy Business (2018-2023) & (US$ Million) Table 61. Horizon Pharma Recent Development Table 62. KannaLife Sciences Company Detail Table 63. KannaLife Sciences Business Overview Table 64. KannaLife Sciences Overt Hepatic Encephalopathy Product Table 65. KannaLife Sciences Revenue in Overt Hepatic Encephalopathy Business (2018-2023) & (US$ Million) Table 66. KannaLife Sciences Recent Development Table 67. Ocer Therapeutics Company Detail Table 68. Ocer Therapeutics Business Overview Table 69. Ocer Therapeutics Overt Hepatic Encephalopathy Product Table 70. Ocer Therapeutics Revenue in Overt Hepatic Encephalopathy Business (2018-2023) & (US$ Million) Table 71. Ocer Therapeutics Recent Development Table 72. Rebiotix Company Detail Table 73. Rebiotix Business Overview Table 74. Rebiotix Overt Hepatic Encephalopathy Product Table 75. Rebiotix Revenue in Overt Hepatic Encephalopathy Business (2018-2023) & (US$ Million) Table 76. Rebiotix Recent Development Table 77. Spherium Biomed Company Detail Table 78. Spherium Biomed Business Overview Table 79. Spherium Biomed Overt Hepatic Encephalopathy Product Table 80. Spherium Biomed Revenue in Overt Hepatic Encephalopathy Business (2018-2023) & (US$ Million) Table 81. Spherium Biomed Recent Development Table 82. Umecrine Cognition Company Detail Table 83. Umecrine Cognition Business Overview Table 84. Umecrine Cognition Overt Hepatic Encephalopathy Product Table 85. Umecrine Cognition Revenue in Overt Hepatic Encephalopathy Business (2018-2023) & (US$ Million) Table 86. Umecrine Cognition Recent Development Table 87. ASKA Pharmaceutical Company Detail Table 88. ASKA Pharmaceutical Business Overview Table 89. ASKA Pharmaceutical Overt Hepatic Encephalopathy Product Table 90. ASKA Pharmaceutical Revenue in Overt Hepatic Encephalopathy Business (2018-2023) & (US$ Million) Table 91. ASKA Pharmaceutical Recent Development Table 92. Mallinckrodt Company Detail Table 93. Mallinckrodt Business Overview Table 94. Mallinckrodt Overt Hepatic Encephalopathy Product Table 95. Mallinckrodt Revenue in Overt Hepatic Encephalopathy Business (2018-2023) & (US$ Million) Table 96. Mallinckrodt Recent Development Table 97. Valeant Company Detail Table 98. Valeant Business Overview Table 99. Valeant Overt Hepatic Encephalopathy Product Table 100. Valeant Revenue in Overt Hepatic Encephalopathy Business (2018-2023) & (US$ Million) Table 101. Valeant Recent Development Table 102. Research Programs/Design for This Report Table 103. Key Data Information from Secondary Sources Table 104. Key Data Information from Primary Sources List of Figures Figure 1. Global Overt Hepatic Encephalopathy Market Size Comparison by Type (2023-2029) & (US$ Million) Figure 2. Global Overt Hepatic Encephalopathy Market Share by Type: 2022 VS 2029 Figure 3. Type A (Acute Liver Failure) Features Figure 4. Type B (Portal Systemic Bypass Without Liver Disease) Features Figure 5. Type C (Liver Cirrhosis) Features Figure 6. Global Overt Hepatic Encephalopathy Market Size Comparison by Application (2023-2029) & (US$ Million) Figure 7. Global Overt Hepatic Encephalopathy Market Share by Application: 2022 VS 2029 Figure 8. Hospitals Case Studies Figure 9. Research Institutes Case Studies Figure 10. Clinics Case Studies Figure 11. Others Case Studies Figure 12. Overt Hepatic Encephalopathy Report Years Considered Figure 13. Global Overt Hepatic Encephalopathy Market Size (US$ Million), Year-over-Year: 2018-2029 Figure 14. Global Overt Hepatic Encephalopathy Market Size, (US$ Million), 2018 VS 2022 VS 2029 Figure 15. Global Overt Hepatic Encephalopathy Market Share by Region: 2022 VS 2029 Figure 16. Global Overt Hepatic Encephalopathy Market Share by Players in 2022 Figure 17. Global Top Overt Hepatic Encephalopathy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Overt Hepatic Encephalopathy as of 2022) Figure 18. The Top 10 and 5 Players Market Share by Overt Hepatic Encephalopathy Revenue in 2022 Figure 19. North America Overt Hepatic Encephalopathy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 20. North America Overt Hepatic Encephalopathy Market Share by Country (2018-2029) Figure 21. United States Overt Hepatic Encephalopathy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 22. Canada Overt Hepatic Encephalopathy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 23. Europe Overt Hepatic Encephalopathy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 24. Europe Overt Hepatic Encephalopathy Market Share by Country (2018-2029) Figure 25. Germany Overt Hepatic Encephalopathy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 26. France Overt Hepatic Encephalopathy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 27. U.K. Overt Hepatic Encephalopathy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 28. Italy Overt Hepatic Encephalopathy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 29. Russia Overt Hepatic Encephalopathy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 30. Nordic Countries Overt Hepatic Encephalopathy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 31. Asia-Pacific Overt Hepatic Encephalopathy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 32. Asia-Pacific Overt Hepatic Encephalopathy Market Share by Region (2018-2029) Figure 33. China Overt Hepatic Encephalopathy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 34. Japan Overt Hepatic Encephalopathy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 35. South Korea Overt Hepatic Encephalopathy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 36. Southeast Asia Overt Hepatic Encephalopathy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 37. India Overt Hepatic Encephalopathy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 38. Australia Overt Hepatic Encephalopathy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 39. Latin America Overt Hepatic Encephalopathy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 40. Latin America Overt Hepatic Encephalopathy Market Share by Country (2018-2029) Figure 41. Mexico Overt Hepatic Encephalopathy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 42. Brazil Overt Hepatic Encephalopathy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 43. Middle East & Africa Overt Hepatic Encephalopathy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 44. Middle East & Africa Overt Hepatic Encephalopathy Market Share by Country (2018-2029) Figure 45. Turkey Overt Hepatic Encephalopathy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 46. Saudi Arabia Overt Hepatic Encephalopathy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 47. Alfa Wassermann Revenue Growth Rate in Overt Hepatic Encephalopathy Business (2018-2023) Figure 48. Cosmo Pharmaceuticals Revenue Growth Rate in Overt Hepatic Encephalopathy Business (2018-2023) Figure 49. Horizon Pharma Revenue Growth Rate in Overt Hepatic Encephalopathy Business (2018-2023) Figure 50. KannaLife Sciences Revenue Growth Rate in Overt Hepatic Encephalopathy Business (2018-2023) Figure 51. Ocer Therapeutics Revenue Growth Rate in Overt Hepatic Encephalopathy Business (2018-2023) Figure 52. Rebiotix Revenue Growth Rate in Overt Hepatic Encephalopathy Business (2018-2023) Figure 53. Spherium Biomed Revenue Growth Rate in Overt Hepatic Encephalopathy Business (2018-2023) Figure 54. Umecrine Cognition Revenue Growth Rate in Overt Hepatic Encephalopathy Business (2018-2023) Figure 55. ASKA Pharmaceutical Revenue Growth Rate in Overt Hepatic Encephalopathy Business (2018-2023) Figure 56. Mallinckrodt Revenue Growth Rate in Overt Hepatic Encephalopathy Business (2018-2023) Figure 57. Valeant Revenue Growth Rate in Overt Hepatic Encephalopathy Business (2018-2023) Figure 58. Bottom-up and Top-down Approaches for This Report Figure 59. Data Triangulation Figure 60. Key Executives Interviewed

Alfa Wassermann Cosmo Pharmaceuticals Horizon Pharma KannaLife Sciences Ocer Therapeutics Rebiotix Spherium Biomed Umecrine Cognition ASKA Pharmaceutical Mallinckrodt Valeant